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Background: A novel coronavirus, named the Middle East Res-
piratory Syndrome coronavirus (MERS-CoV), was ﬁrst identiﬁed
in humans in 2012. MERS infections are characterized by acute
respiratory distress with fatal cases often diagnosed with comor-
bidity factors including diabetes, cardiovascular disease, or obesity.
Continued emergence of MERS-CoV, coupled with a lack of under-
standing of the natural history of MERS highlights the importance
of identifying therapeutics for treatment ofMERS-CoV infections in
humans. Like other coronaviruses, the MERS-CoV virion utilizes a
large surface spike (S) glycoprotein for interaction with and entry
into the target cell. The host cell protein dipeptidyl peptidase 4
(DPP4, akaCD26)was identiﬁed as a cellular receptor forMERS-CoV
and the speciﬁc interaction of the receptor-binding domain (RBD)
of MERS-CoV spike protein and DPP4 was determined recently by
crystallography.
Methods & Materials: Our laboratory has been working to
develop rational in vitro and in vivo models of MERS-CoV infection
to allow better understanding of the pathogenesis and transmis-
sion potential of virus, and also to evaluate potential therapeutic
and vaccine approaches to treat or prevent MERS in humans. Here
we present studies focused on characterization of the MERS-CoV
receptor, DPP4 in cells from theAmericanmink (Neovision vision) as
well evaluation ofmink as an animalmodel ofMERS-CoV infection.
Using multiple approaches we have shown a cell line derived from
mink lung epithelium to be susceptible to infection by MERS-CoV.
Results:Western blot and PCR analysis ofmink lung epithelium
cells demonstrate the presence of DPP4, the receptor for MERS-
CoV expressed in mink, suggesting a role for this receptor in viral
entry in this species. Characterization of the expression of DPP4 in
mink cells reveal multiple isoforms, which show varying patterns
of expression in cells transfected with each DPP4 isoform using
confocal microscopy.
Conclusion: In conclusion, evaluationof knownDDP4 inhibitors
for antiviral activity againstMERS-CoV reveal potential therapeutic
approaches to treatment of MERS with existing, licensed com-
pounds. Studies underway using mink as an in vivo model of
MERS-CoV infection and pathogenesis support it’s use in discov-
ery and development of therapeutic and vaccines for MERS-CoV in
humans.
http://dx.doi.org/10.1016/j.ijid.2016.02.079
Type: Oral Presentation
Final Abstract Number: 14.006
Session:Oral Presentations: Emerging InfectiousDiseases&OneHealth
Date: Thursday, March 3, 2016
Time: 15:45-17:45
Room: G.05-06
Multiple introductions of MERS-CoV in a 2014
hospital outbreak in Riyadh, Saudi Arabia
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Background: In 2012, the Middle East respiratory syndrome
(MERS), a zoonotic disease causedby theMERSCoronavirus (MERS-
CoV) emerged in Saudi Arabia as a disease with global health
implications. Though much of its transmission dynamics remain
unclariﬁed, most cases (over 1250) have occurred in Saudi Arabia
with substantial contribution from hospital outbreaks. This molec-
ular epidemiological study investigated a MERS outbreak at the
King Fahad Medical City (KFMC), a 1,200-bed tertiary care hospital
in Riyadh that occurred between March 29 and May 21, 2014.
Methods & Materials: Following MOH guidelines, respiratory
specimens (nasopharyngeal swab, tracheal aspirate or bron-
choalveolar lavage) from persons including health care workers
(HCWs) suspected to have MERS-CoV infection were tested using a
reverse transcription PCR targeting the Orf1a and upstream E-gene
(upE). In parallel, these samples were tested for 15 other respi-
ratory viruses using a Multiplex PCR platform. Epidemiologic data
were extracted from electronic health records, sick leave records of
HCWs and direct interviews. Stored remnants of PCR positive sam-
ples were retrieved and sent to The University of Hong Kong where
overlapping PCR products generated from multiple sets of PCR on
synthesized cDNA were used to sequenced the entire MERS-CoV
genome with >3–5 times genome coverage. BEAST (version 1.8)
was used for phylogenetic analysis.
Results: 45 MERS-CoV infected persons were documented
during this period: 23 HCWs; 13 long stay in-patients; and 8
patients infected outside KFMC. The source of infection for 1 person
was inconclusive. Comparison of retrieved full-length MERS-CoV
sequences from 10 patients and a partial sequence from another
with other publicly available MERS-CoV sequences revealed that
this outbreak was part of a larger outbreak that involved several
hospitals in Riyadh. The larger outbreak seemed to have origi-
nated from a zoonotic transmission event around December 2013
(95%highestposteriordensity intervalNovember8, 2013–February
10, 2014) thus indicative of probable sustained human-to-human
spread over a 5-month period.
Conclusion: Using whole genome sequencing, we demon-
strated multiple introductions of MERS-CoV in a hospital outbreak
that was hitherto thought to be otherwise.
http://dx.doi.org/10.1016/j.ijid.2016.02.080
